Australian device maker strikes partnership with the U.S. Oncology Network
Impedimed, which is headquartered in Australia, makes a tool for early detection of lymphedema in cancer patients.
Impedimed, which is headquartered in Australia, makes a tool for early detection of lymphedema in cancer patients.
The insurer said it will provide compensation for better care navigation based on quality and cost metrics across various parts of the patient journey ranging from inpatient admissions, ED visits, prescription drugs, diagnostics and radiology.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.